Event preview: Drug Discovery Week Europe
3 October 2014 | By GTCbio
From 7-10 October 2014, GTCbio will proudly present its Drug Discovery Week Europe event in the beautiful city of Dublin, Ireland...
List view / Grid view
News
Allied-Bristol Life Sciences appoints Satish Jindal to lead the discovery of drug candidates from leading academic institutions
3 October 2014 | By Allied-Bristol Life Sciences
Allied-Bristol Life Sciences today announced that Satish Jindal, Ph.D., formerly Vice President of R&D within Bristol-Myers, has been appointed to lead the company’s efforts to identify and foster development of biopharmaceutical innovations from top U.S. university research institutions...
Thermo Scientific TGA-IR Module enhances materials characterization for users of Thermo Scientific FT-IR Spectrometers
1 October 2014 | By Thermo Fisher Scientific
Scientists involved in materials characterization, process validation and product failure analysis can gather more valuable data by combining two powerful analytical techniques...
Cardio3 BioSciences announces new business development strategy to broaden its product pipeline
1 October 2014 | By Cardio3 BioSciences
Cardio3 BioSciences announces that it has recently increased its business development activities, building on its core expertise in cellular therapies and in cardiovascular diseases...
Avacta Life Sciences takes on the $55bn antibody market with launch of Affimers
1 October 2014 | By Avacta Life Sciences
Avacta Life Sciences is investing £10m in the launch of Affimers, the engineered alternative to antibodies...
Roche purchases shares in tender offer for InterMune, Inc.
30 September 2014 | By Roche
Roche and InterMune, Inc. announced that Roche’s wholly owned subsidiary Klee Acquisition Corporation has accepted for payment all shares validly tendered pursuant to its tender offer for all outstanding shares of common stock of InterMune, Inc. at USD 74.00 per share in cash...
Daiichi Sankyo to acquire Ambit Biosciences
30 September 2014 | By Daiichi Sankyo
Lead compound, Quizartinib, will further build Daiichi Sankyo oncology pipeline...
Horizon Discovery Group plc acquires Sage Labs Inc. for $48M (£29M)
29 September 2014 | By Horizon Discovery Group
Horizon Discovery Group plc announced it has agreed to acquire Sage Labs Inc...
Tumour profiling with Caris Molecular Intelligence offers hope for patients with rare cancers by identifying new personalised treatment options
29 September 2014 | By Caris Life Sciences
Caris Life Sciences announced important new data presented at the European Society for Medical Oncology Annual Conference, highlighting how tumour profiling with Caris Molecular Intelligence can help transform cancer care...
Kymab strengthens and expands capabilities through Board appointments and Executive promotions
29 September 2014 | By Kymab
Following a US$40 million Series B investment from The Wellcome Trust and the Bill & Melinda Gates Foundation...
SIGMOID enters into a licence agreement with Pendopharm for commercialisation rights to CyCol® in Canada
29 September 2014 | By SIGMOID PHARMA LIMITED
SIGMOID PHARMA LIMITED and Pendopharm have entered into agreements concerning a licence for exclusive rights to commercialise CyCol® in the Canadian market and an equity investment in SIGMOID...
EATRIS enters framework agreement with Roche to access Europe-wide network of translational researchers
26 September 2014 | By EATRIS
EATRIS has signed a formal framework agreement with the Roche Partnering Extending Innovation Network (EIN) program...
Pfizer completes acquisition of InnoPharma
26 September 2014 | By Pfizer
Pfizer Inc. announced that it has completed its acquisition of the pharmaceutical development company, InnoPharma, Inc., following receipt of United States (U.S.) regulatory approval from all government authorities required by the agreement and other closing conditions...
Guidelines raise standards for contamination control
25 September 2014 | By Ecolab
Recent guidelines aimed at raising standards of contamination control in the pharmaceutical industry mean organisations need to assess their current practices...
SGS announces completion of new life science services laboratory in Carson, California
25 September 2014 | By SGS Life Science Services
SGS Life Science Services announced the the completion of its fifth North American Life Science Services laboratory, in Carson, California...
